ArticlePharmaceutics2024

Pharmacokinetic Evaluation of Neutral Sphinghomyelinase2 (nSMase2) Inhibitor Prodrugs in Mice and Dogs.

Arina Ranjit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.